57 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
to the termination and by the Company, without notice, immediately upon the occurrence of any default by Dr. Kevin McElwee.
Oversight and Description … Committee
The Audit Committee is a standing committee of the Board. The role of the Audit Committee is to:
(a) assist the Board in its oversight
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Aug 23
Statement of Executive Compensation
7:41pm
, immediately upon the occurrence of any default by Dr. Kevin McElwee.
Oversight and Description of Director and NEO Compensation
Compensation Process
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
on our audits. We are a public accounting firm registered with the Public Accounting Oversight Board (United States) ("PCAOB") and are required
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
28 Jul 22
Current report (foreign)
2:52pm
organization), as Chair of FIRM’s Specific Process Cells Committee intended to bring increased rigor and industry oversight to the development, manufacture
6-K
EX-99.1
p7zc3 bve
7 Jul 22
Statement of Executive Compensation
1:43pm
6-K
EX-99.1
lhft5gnb8npni6aw
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.1
e55wpf
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
43qwgi3ssbprshj225m
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.3
338xm5z8s19jwaox6
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.5
gj02hh
18 Aug 21
Current report (foreign)
12:20pm
20-F/A
fkj3344x
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
xoeco3y5qh p4sslxs
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
t90rqchr
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
nva582y2
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
8qlz4 s8tfh3lvjxh
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am